We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
75 hedge funds and large institutions have $477M invested in Atara Biotherapeutics in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
38% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 21
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
3% more funds holding
Funds holding: 73 → 75 (+2)
3% less capital invested
Capital invested by funds: $493M → $477M (-$15.4M)
Holders
75
Holders Change
+2
Holders Change %
+2.74%
% of All Funds
2%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
9
Increased
29
Reduced
21
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.88M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$8.8M |
| 3 |
AG
Artal Group
Luxembourg
|
+$4.89M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$1.85M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.46M |
Top Sellers
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$8.41M |
| 2 |
UBS AM
Chicago,
Illinois
|
-$6.51M |
| 3 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$2.68M |
| 4 |
JP Morgan Chase
New York
|
-$2.03M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$602K |
